pharmaceuticals

GSK plc (NYSE:GSK) on Tuesday agreed to acquire Boston-based biotech firm Nuvalent, Inc. (NASDAQ:NUVL) for $10.6 billion in cash as the British drugmaker seeks to strengthen its lung cancer portfolio. Under the agreement, GSK will acquire all outstanding Nuvalent shares for $124 each in...

Revolution Medicines Inc. (NASDAQ:RVMD), on Sunday, unveiled breakthrough data showing its experimental pancreatic cancer pill more than doubled median overall survival compared with chemotherapy in a pivotal study. The Survival Benefit Daraxonrasib reduced the risk of death by 60% versus...

White House economists have reportedly estimated that the agreements President Donald Trump has made with pharmaceutical companies to reduce U.S. prescription drug prices could lead to savings of $529 billion over the next decade. The analysis was carried out by administration...

Takeda Pharmaceutical Co Ltd (NYSE:TAK) shares are down on Friday morning as the company is reportedly demonstrating positive Phase 3 data for its drug Entyvio. This news comes as the broader market experienced mixed performance, with the S&P 500 and Nasdaq both showing slight gains while the...

SciSparc Ltd. (NASDAQ:SPRC) traded higher after the company announced it had signed a definitive agreement to acquire a controlling stake in Miza III Ventures Inc. (TSXV:MIZA), a publicly traded firm on Canada's TSX Venture Exchange The Tel Aviv-based pharmaceutical company develops treatments for...

Eli Lilly and Co. (NASDAQ:LLY) plans to invest over $1 billion in India to strengthen its manufacturing network, according to Reuters. The move aims to tap into the country's skilled workforce and support Lilly's global expansion. The collaborations are designed to increase the availability of key...

Kala Bio Inc. (NASDAQ: KALA) stock is down on Monday after the company halted development of its experimental treatment for a specific eye condition. The company had a session volume of 14.04 million compared to the average volume of 216.47 thousand, according to data from Benzinga Pro. On Monday,...

Editor’s Note: This article has been updated to correct an earlier inaccuracy regarding the company’s stock trajectory. Nektar Therapeutics Inc. (NASDAQ:NKTR) on Thursday shared new data from its ongoing REZOLVE-AD Phase 2b study of rezpegaldesleukin, an IL-2 pathway agonist and...

Novo Nordisk A/S (NYSE:NVO) is trading higher on Friday. It is just below resistance around the $58 level. Novo has been in a major downtrend since June 2024. Since then, it has lost about 60% of its value. But there is a chance that a reversal may be taking place. This is why it is our Stock of...

Monte Rosa Therapeutics Inc. (NASDAQ:GLUE) stock is surging on Monday, with a session volume of 11.67 million compared to the average volume of 408.08 thousand as per data from Benzinga Pro. Monte Rosa announced a collaboration with Novartis AG (NYSE:NVS) to develop novel degraders for immune-...

On Saturday, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) released new Phase 3 PEGASUS study results on Saturday. The data show that its therapy Palynziq (pegvaliase-pqpz) significantly reduced blood phenylalanine (Phe) levels in adolescents with phenylketonuria (PKU), a rare metabolic disorder. The...

Eli Lilly and Co. (NYSE:LLY) stock has experienced significant volatility over the past six months, primarily driven by reactions to developments in its weight-loss drug portfolio.  Lilly stock popped on Tuesday after the company announced that its oral GLP-1 pill helped patients lose an average of...

AbbVie Inc. (NYSE:ABBV) announced Monday that it will acquire Gilgamesh Pharmaceuticals Inc.’s lead investigational candidate for moderate-to-severe major depressive disorder (MDD). The deal, valued at up to $1.2 billion, includes an upfront payment and development milestones for the...

Cognition Therapeutics Inc (NASDAQ:CGTX) rose 12.10% to $0.45 during after hours on Thursday, following a surge of 20.82% gain during regular hours.  What Happened: The hike in Cognition Therapeutics’ stock price is attributed to the promising results from its Alzheimer’s drug,...

Bone Biologics Corporation (NASDAQ:BBLG) stock is trading higher on Friday, with a session volume of 17.22 million compared to the average volume of 38.795K as per data from Benzinga Pro. The company filed a patent application with the U.S. Patent and Trademark Office (USPTO) for its preclinical...